Innovation Pharmaceuticals Inc (IPIX)

[frrol]

Still not clear to me. You wrote:

Brilacidin has 5 censoring marks on or after day 77 which is presumably the last day to observe severe OM incidence, placebo has 3. These probably [re]present subjects that did not have severe OM incident before day 77 and are therefore administratively censored as subjects that don't count anymore neither against incidents or durations

Why would such folks not count as participants who did not develop SOM and therefore lower the charted "proportion" line? Do you mean to say those patients did develop SOM but too late for the study? Not getting your argument.